Milbemycin EP Impurity E
| Catalog No. | KMM136007 |
|---|---|
| CAS No. | 86691-97-6 |
| Formula | C32H44O7 |
| FW | 540.7 |
| Unit | Price | Stock |
|---|---|---|
| 100 mg | Enquire | Enquire |
| Chemical Name: | (1′R,2R,4′S,5S,6R,8′R,10′E,13′R,14′E,16′E,20′S,24′S)-6-Ethyl-24′-hydroxy-5,11′,13′,22′-tetramethyl-3,4,5,6-tetrahydrospiro[pyran-2,6′-[3,7,19 ]trioxa tetracyclo-[15.6.1.14,8.020,24]pentacosa[10,14,16,22]tetraene]-2′,21′-dione ; |
|---|---|
| Purity: | >95% |
| Storage: | Store at 2-8 deg. C for long term storage |
| Shipping: | Product is stable to be Shipped at Room Temperature |
Milbemycin EP Impurity E is chemically (1′R,2R,4′S,5S,6R,8′R,10′E,13′R,14′E,16′E,20′S,24′S)-6-Ethyl-24′-hydroxy-5,11′,13′,22′-tetramethyl-3,4,5,6-tetrahydrospiro[pyran-2,6′-[3,7,19 ]trioxa tetracyclo-[15.6.1.14,8.020,24]pentacosa[10,14,16,22]tetraene]-2′,21′-dione ; .
Milbemycin EP Impurity E is supplied with detailed characterization data compliant with regulatory guideline.
Milbemycin EP Impurity E can be used for the analytical method development, method validation (AMV), Quality Controlled (QC)
application for Abbreviated New Drug Application (ANDA) or during commercial production of Milbemycin EP Impurity E.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
Related Products
CAT No: KMM136002
CAT No: KMM136001
CAT No: KMM136003
CAT No: KMM136004
CAT No: KMM136005
CAT No: KMM136006
CAT No: KMM136008
CAT No: KMM136009
CAT No: KMM136010
CAT No: KMM136011
CAT No: KMM136012
